# PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pd-l1-strong-expressions-affect-the-clinical-outcomes-of-osimertinib-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kuo-Hsuan Hsu,Jeng‐Sen Tseng,Tsung‐Ying Yang,Kun‐Chieh Chen,Kang‐Yi Su,Sung‐Liang Yu,Jeremy J.W. Chen,Yen-Hsiang Huang,Gee‐Chen Chang |
| Citations | 42 |
| DOI | 10.1038/s41598-022-13102-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41598-022-13102-7.pdf |
| OpenAlex ID | https://openalex.org/W4282585284 |
| PMID | 35697720 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jeng‐Sen Tseng](https://scholariq.org/researchers/jeng-sen-tseng/)

## Paper journal

- [Scientific Reports](https://scholariq.org/journals/scientific-reports/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.